MARKER OF DIAGNOSIS AND PROGNOSIS IN MULTIPLE SCLEROSIS
摘要
The present invention provides a method for determining whether an individual with relapsing-remitting multiple sclerosis will suffer a relapse. In the method, measuring the level of Response Gene to Complement (RGC)-32 is measured in the individual, where a significantly lower level of RGC-32 therein indicates that the individual will have or is having a relapse of multiple sclerosis.
申请公布号
WO2012026979(A2)
申请公布日期
2012.03.01
申请号
WO2011US01487
申请日期
2011.08.24
申请人
UNIVERSITY OF MARYLAND, BALTIMORE;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS;RUS, HOREA;TEGLA, COSMIN;CUDRICI, CORNELIA